Evaluation of the Novel Myocardial Perfusion Positron-Emission Tomography Tracer 18F-BMS-747158-02: Comparison to 13N-Ammonia and Validation With Microspheres in a Pig Model
暂无分享,去创建一个
S. Nekolla | T. Schuster | S. Robinson | M. Schwaiger | A. Saraste | J. Henke | A. Preissel | M. Huisman | T. Higuchi | H. Wester | A. Saraste | S. Reder | S.G. Nekolla | S. Reder | T. Higuchi | G. Dzewas | A. Preissel | M. Huisman | T. Poethko | T. Schuster | M. Yu | S. Robinson | D. Casebier | J. Henke | H.J. Wester | M. Schwaiger | T. Poethko | Hans-Juergen Wester | Ming Yu | D. Casebier | M. Yu | M. Huisman | S. Reder | G. Dzewas | D. Casebier | Thorsten Poethko | Tibor Schuster | Julia Henke
[1] G. Paradies,et al. Decrease in Mitochondrial Complex I Activity in Ischemic/Reperfused Rat Heart: Involvement of Reactive Oxygen Species and Cardiolipin , 2004, Circulation research.
[2] Teresa Houston,et al. Impact of Myocardial Perfusion Imaging with PET and 82Rb on Downstream Invasive Procedure Utilization, Costs, and Outcomes in Coronary Disease Management , 2007, Journal of Nuclear Medicine.
[3] O Muzik,et al. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] D E Kuhl,et al. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. , 1990, Journal of the American College of Cardiology.
[5] S. Robinson,et al. Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[6] M. D. Di Carli,et al. New technology for noninvasive evaluation of coronary artery disease. , 2007, Circulation.
[7] William H. Press,et al. Numerical recipes in C , 2002 .
[8] S. Robinson,et al. Mechanism of uptake and retention of F-18 BMS-747 158-02 in cardiomyocytes: a novel PET myocardial imaging agent , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[9] J. Leppo,et al. Myocardial uptake of 99mTc-tetrofosmin, sestamibi, and 201Tl in a model of acute coronary reperfusion. , 1996, Circulation.
[10] René M. Botnar,et al. A New 18F-Labeled Myocardial PET Tracer: Myocardial Uptake After Permanent and Transient Coronary Occlusion in Rats , 2008, Journal of Nuclear Medicine.
[11] L. Becker,et al. Assessment of Severity of Coronary Artery Stenosis in a Canine Model Using the PET Agent 18F-Fluorobenzyl Triphenyl Phosphonium: Comparison with 99mTc-Tetrofosmin , 2007, Journal of Nuclear Medicine.
[12] M. Phelps,et al. First human study of BMS747158, a novel F-18 labeled tracer for myocardial perfusion imaging , 2008 .
[13] Michael Kreissl,et al. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. , 2005, Journal of the American College of Cardiology.
[14] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.
[15] P. Kaufmann,et al. Myocardial blood flow measurement by PET: technical aspects and clinical applications. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] N. Mullani,et al. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] R. Gropler,et al. Journey to find the ideal PET flow tracer for clinical use: Are we there yet? , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[18] D. Pennell,et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[19] R Guzzardi,et al. Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] I. Olivotto,et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.
[21] D. Neglia,et al. Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction , 2002, Circulation.
[22] Brian H Annex,et al. Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis. , 2003, Journal of applied physiology.
[23] J. Casida,et al. The insecticide target in the PSST subunit of complex I. , 2001, Pest management science.
[24] Stephan G. Nekolla,et al. Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography , 1998, European Journal of Nuclear Medicine.
[25] S. Rohrbach,et al. Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression. , 2002, Journal of the American College of Cardiology.
[26] S. Nekolla,et al. Initial Characterization of an 18F-Labeled Myocardial Perfusion Tracer , 2008, Journal of Nuclear Medicine.
[27] Mary Guaraldi,et al. BMS-747 158-02: A novel PET myocardial perfusion imaging agent , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[28] M. Schwaiger,et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. , 2000, The New England journal of medicine.
[29] Raymond Kwong,et al. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. , 2007, Journal of the American College of Cardiology.
[30] J I Hoffman,et al. Blood flow measurements with radionuclide-labeled particles. , 1977, Progress in cardiovascular diseases.
[31] Michael G Stabin,et al. Radiopharmaceuticals for Nuclear Cardiology: Radiation Dosimetry, Uncertainties, and Risk , 2008, Journal of Nuclear Medicine.
[32] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[33] W. Hirth,et al. The Noah's Ark experiment: species dependent biodistributions of cationic 99mTc complexes. , 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.